OTCMKTS:EKTAY Elekta AB (publ) (EKTAY) Stock Price, News & Analysis $6.13 -0.02 (-0.33%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$6.13▼$6.1550-Day Range$6.04▼$8.2352-Week Range$6.04▼$8.62Volume14,225 shsAverage Volume10,097 shsMarket CapitalizationN/AP/E Ratio19.16Dividend Yield2.61%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendEarningsFinancialsHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendEarningsFinancialsHeadlinesShort Interest Get Elekta AB (publ) alerts: Email Address Elekta AB (publ) MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestBearishDividend StrengthModerateBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings Growth15.00%From $0.40 to $0.46 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.69 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Elekta AB (publ).Read more about Elekta AB (publ)'s stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares ShortedShort Interest Ratio / Days to CoverElekta AB (publ) has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Elekta AB (publ) has recently increased by 80.00%, indicating that investor sentiment is decreasing significantly. Previous Next 2.5 Dividend Strength Dividend YieldElekta AB (publ) pays a meaningful dividend of 2.56%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthElekta AB (publ) does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Elekta AB (publ) is 50.00%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Elekta AB (publ) will have a dividend payout ratio of 34.78% next year. This indicates that Elekta AB (publ) will be able to sustain or increase its dividend.Read more about Elekta AB (publ)'s dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EKTAY. Previous Next 0.6 News and Social Media Coverage News SentimentElekta AB (publ) has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Elekta AB (publ) this week, compared to 0 articles on an average week. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Elekta AB (publ) insiders have not sold or bought any company stock.Percentage Held by Insiders41.28% of the stock of Elekta AB (publ) is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about Elekta AB (publ)'s insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Elekta AB (publ) are expected to grow by 15.00% in the coming year, from $0.40 to $0.46 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Elekta AB (publ) is 19.16, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 143.26.Price to Earnings Ratio vs. SectorThe P/E ratio of Elekta AB (publ) is 19.16, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 169.33.Price to Book Value per Share RatioElekta AB (publ) has a P/B Ratio of 2.32. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Elekta AB (publ) Stock (OTCMKTS:EKTAY)Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.Read More EKTAY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EKTAY Stock News HeadlinesMarch 1, 2024 | gurufocus.comQ3 2024 Elekta AB (publ) Earnings Call TranscriptFebruary 23, 2024 | msn.comElekta AB (publ) goes ex dividend MondayJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.February 20, 2024 | finance.yahoo.comIs Elekta (EKTAY) Stock Undervalued Right Now?December 17, 2023 | msn.comElekta AB - ADR (EKTAY) Price Target Increased by 5.21% to 8.43December 7, 2023 | finance.yahoo.comIs Elekta (EKTAY) a Great Value Stock Right Now?November 27, 2023 | msn.comElekta AB - ADR (EKTAY) Price Target Increased by 6.97% to 8.01November 9, 2023 | morningstar.comElekta AB ADR EKTAYJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.November 8, 2023 | msn.comElekta gets $40m radiation tech contract from India’s KIMSOctober 23, 2023 | stockhouse.comiCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to ElektaAugust 26, 2023 | seekingalpha.comElekta AB (publ) 2024 Q1 - Results - Earnings Call PresentationAugust 26, 2023 | seekingalpha.comElekta AB (publ) (EKTAF) Q1 2024 Earnings Call TranscriptJuly 19, 2023 | wsj.comElekta AB Series BApril 30, 2023 | seekingalpha.comEpiroc AB (publ) 2023 Q1 - Results - Earnings Call PresentationNovember 24, 2022 | finance.yahoo.comEuropean shares struggle for direction as traders weigh rate outlookNovember 5, 2022 | finance.yahoo.comElekta AB (publ) (EKTAY)October 13, 2022 | finance.yahoo.comElekta AB (publ) (EKTA-B.ST)See More Headlines Receive EKTAY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Elekta AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/05/2024Today7/26/2024Fiscal Year End4/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolOTCMKTS:EKTAY CUSIPN/A CIK1451160 Webwww.elekta.com Phone(685) 872-5400Fax46-8-587-255-00Employees4,540Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.32 Trailing P/E Ratio19.16 Forward P/E Ratio15.33 P/E GrowthN/ANet Income$122.52 million Net Margins7.19% Pretax Margin9.21% Return on Equity13.27% Return on Assets4.43% Debt Debt-to-Equity Ratio0.45 Current Ratio1.00 Quick Ratio0.76 Sales & Book Value Annual Sales$1.70 billion Price / SalesN/A Cash Flow$0.61 per share Price / Cash Flow10.06 Book Value$2.64 per share Price / Book2.32Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta1.22 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Laurent Leksell (Age 72)Founder & Chairman Comp: $1.64MMr. Gustaf Salford (Age 47)President & CEO Comp: $14.62MMr. Tobias Hagglov (Age 46)Chief Financial Officer Mr. Peter Nyquist (Age 59)Head of Investor Relations Mr. Jonas Bolander (Age 58)Executive VP of Group Functions, Secretary & General Counsel Mr. Mattias ThorssonVP and Head of Corporate Communications & Public AffairsMs. Anna Conneryd Lundgren (Age 39)Executive VP & Chief People Officer Mr. John Lapré (Age 60)President of Brachy & Neuro Solutions Mr. Maurits Wolleswinkel (Age 53)President of Linac & Software Solutions Mr. Habib Nehme (Age 60)Chief Commercial Officer More ExecutivesKey CompetitorsACI GlobalOTCMKTS:ACGJAeon Global HealthOTCMKTS:AGHCCentogeneNASDAQ:CNTGGeneLinkOTCMKTS:GNLKQMDxHealthNASDAQ:MDXHView All Competitors EKTAY Stock Analysis - Frequently Asked Questions How have EKTAY shares performed this year? Elekta AB (publ)'s stock was trading at $8.1495 at the start of the year. Since then, EKTAY stock has decreased by 24.8% and is now trading at $6.13. View the best growth stocks for 2024 here. How were Elekta AB (publ)'s earnings last quarter? Elekta AB (publ) (OTCMKTS:EKTAY) announced its earnings results on Wednesday, June, 5th. The company reported $0.11 earnings per share for the quarter. The company had revenue of $475.78 million for the quarter. Elekta AB (publ) had a net margin of 7.19% and a trailing twelve-month return on equity of 13.27%. How do I buy shares of Elekta AB (publ)? Shares of EKTAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:EKTAY) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elekta AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Elekta AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.